Pacira BioSciences, Inc. (PCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
73.68-3.48 (-4.51%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 77.16 |
| Open | 74.50 |
| Bid | 45.10 x 1100 |
| Ask | 81.08 x 900 |
| Day's Range | 73.23 - 77.45 |
| 52 Week Range | 27.46 - 77.89 |
| Volume | 550,587 |
| Avg. Volume | 473,107 |
| Market Cap | 3.201B |
| Beta (5Y Monthly) | 1.26 |
| PE Ratio (TTM) | 25.14 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
AMRX or PCRX: Which Is the Better Value Stock Right Now?
AMRX vs. PCRX: Which Stock Is the Better Value Option?
- Investor's Business Daily
Exact Sciences Scores Relative Strength Rating Upgrade; Hits Key Threshold
Exact Sciences saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 75 to 85. As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength. Exact Sciences is now considered extended and out of buy range after clearing a 139.36 buy point in a second-stage cup with handle.
- Investor's Business Daily
Stocks Rebound Into The Close; Tesla Contributes To Nasdaq 100's 1.3% Jump
The stock market rebounded into the close Friday, as the Nasdaq composite and S&P 500 made record highs.
© 2021 Verizon Media. All rights reserved.
